Back to Archived Journals » Comparative Effectiveness Research » Volume 7

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Total article views   HTML views PDF downloads Totals
11,082 Dovepress* 11,082+ 818 11,900
Totals 11,082 818 11,900
*Since 23 January 2017

View citations on Google Scholar